Emergency herbal medicine is one of the most widely used products in the US.
However, the US Food and Drug Administration (FDA) has issued warnings about its potential side effects, and it is one ingredient in a controversial new class of “medical marijuana” that the US Drug Enforcement Administration (DEA) has recommended be labeled as an emergency medicine.
The herbal drug, called kratom, is the world’s most widely-used drug.
It has been used as a remedy in India for decades, with people saying it can alleviate pain and fever and reduce anxiety and depression.
But kratom is also highly addictive, and has been linked to overdose deaths in the UK, Australia and New Zealand.
It has been classified as an opioid, meaning it has the potential to lead to overdose death, and the drug is being prescribed by doctors in the United States to treat conditions including depression, opioid addiction and anxiety.
Kratom is a leaf of the Mitragyna speciosa tree, which is a tree native to Southeast Asia.
In addition to the DEA warning, the FDA has now said that it would not allow kratom to be prescribed by US doctors for pain relief.
The DEA has warned that kratom can increase the risk of addiction to opioids and is therefore not safe to prescribe.
A number of manufacturers have tried to bring kratom back to the US for sale, but there have been concerns about the safety of the drug and its potential for abuse.
In 2014, the DEA banned the import of kratom in the country because of its illegal nature.
Since then, kratom has been legalised in several states, and many people have taken it for relief of their pain.
But the new emergency medical product, called “Kratom” has been marketed in the States under the brand name “Kaya”.
It contains kratom leaf and is believed to contain the same alkaloids found in kratom that are used in the herb for pain.
Kratom is an opioid pain reliever, but it does not have the addictive qualities of opioids.
The drug was created by the company BioMed Research, which also makes the herb “Somari”, a plant used for its medicinal properties.
BioMed has said that kaya can relieve pain and anxiety and can help people recover from conditions including post-traumatic stress disorder (PTSD), fibromyalgia and epilepsy.
It is unclear whether BioMed will continue to sell kratom under the new name “kratom”.
Kaya is available in Canada, the UK and New York.
An Australian website called Kratom UK, which was created to promote the product, has already attracted more than 2,000 users.
It features testimonials from people who say that kapitrol has helped them deal with severe pain, as well as relief from the side effects of opioid painkillers.
“It is an amazing product, it has amazing effects,” one customer, who did not want to be named, told The Independent.
It is a product that I would definitely recommend to anyone that needs help with pain.”